Paratus Sciences
Revealing bats' evolutionary edge for better human therapeutics
Revealing bats' evolutionary edge for better human therapeutics
Paratus Sciences, a biotechnology startup based in the United States, was founded in 2021 with a focus on improving human health and health security through the study of bat biology. The company's slogan "Improving human health and health security through the study of bat biology" reflects its commitment to leveraging the secrets of the bat genome to develop potential therapeutics for a wide range of diseases. Recently, on 27 February 2023, the company secured a substantial $100.00M Series A investment from a notable group of investors including Arch Venture Partners, Polaris Partners, Alexandria Venture Investments, EcoR1 Capital, Leaps by Bayer, and ClavystBio. Paratus Sciences stands at the forefront of biotech and healthcare industries, pioneering research and development efforts to unlock the full potential of bat biology for the betterment of human health.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $100.00M | 6 |
|
27 Feb 2023 |
No recent news or press coverage available for Paratus Sciences.
We care about your data, and we'd love to use cookies make your experience better.
